111,662 followers
Blocking enzyme ACSS2 is a potential way to treat triple-negative #breastcancer, found Komen grantee Dr. Zachary Schug. Read more: https://t.co/PVXi6ocTRK
Blocking enzyme ACSS2 is a potential way to treat triple-negative #breastcancer, found Komen grantee Dr. Zachary Schug. Read more: https://t.co/PVXi6ocTRK
Cool strategy to target lipid biosynthesis in TNBC. https://t.co/Hp5DW21tKT
Targeting ACSS2 with a Transition-State Mimetic Inhibits Triple-Negative Breast Cancer Growth https://t.co/ciXDwTGyWJ
Finally got a chance to read this one!! Several several good bits of science. Awesome work by Kate, @SchugLab and team!!! Congratulations!!